chrisvoncsefalvay/vaers-outcomes huggingface dataset:
extremely fatigued; congested; ended up losing her sense of smell over the weekend; ended up losing her sense of taste over the weekend; headache and terrible sinuses/sinus headaches; felt the scratchiness in her nose; felt the scratchiness in her throat; This is a spontaneous report from a non-contactable healthcare professional. A 30-year-old non-pregnant female patient received her first dose of bnt162b2 (BNT162B2 reported as PFIZER COVID-19 VACCINE; unknown lot number and expiration date), intramuscular left arm on 07Jan2021 14:00 at a single dose for covid-19 immunization. The patient medical history was not reported. There were no concomitant medications. The patient previously took benzoyl peroxide and clindamycin (BENZACLIN) but had allergies. The patient reported that within 4 hours (07Jan2021 06:00 PM), she felt the scratchiness in her throat in and nose. The next morning (08Jan2021), she was extremely fatigued, congested, and ended up losing her sense of taste and smell over the weekend, for the next week. She also had headache and terrible sinuses. Treatment was received for the adverse events. The patient received acetaminophen (TYLENOL) as treatment for sinus headaches. The patient was not diagnosed with Covid prior to vaccination and was not covid tested post vaccination. The outcome of the events was recovering.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Note: Resumption of interrupted Anthrax reactions seem to be occurring more frequently. Edema, erythema.
slight sore arm; Initial information received on 09-Oct-2021 regarding an unsolicited valid Social Media non-serious case received from a consumer/non-health care professional.  This case involves adult patient (unknown age and gender) who experienced slight sore arm (pain in extremity) after receiving vaccine INFLUENZA VACCINE.  It was unknown if the patient had any medical history, concomitant disease or risk factor.  The patient's medical treatment, vaccination, concomitant medication and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date: not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a non-serious slight sore arm (pain in extremity) (unknown latency) following the administration of INFLUENZA VACCINE.  It was reported "Got mine yesterday. Love the expression Flu shot Friday. Not a regular for flu vaccine, but feel this is the time to start. Just a slight sore arm".   It was unknown if there were lab data/results available.  It was not reported if the patient received a corrective treatment.  At time of reporting, the outcome was unknown for the reported event.  There will be no information available on the batch number for this case.
Fatigue. Rest and fluids. Unable to work.  Other symptoms include body aches, difficulty sleeping, headaches, stabbing head pain, anxiety, memory problems, dizziness, chest pressure; cough, joint pain, diarrhea, sore throat, loss of sense of smell, distorted sense of smell, distorted sense of taste, loss of taste, blurry vision, and sadness, throat phglem, nerve pain in hands and feet, covid toe, skin lesions and rashes, heart burn, changing symptoms, eg. nausea, weight gain, tennitus, shakiness in hands and shoulders, excessive sleepiness, constant thirst, nerve sensations, confusion, irritability.
Patient had hives on right side of neck to the nape of neck, bilateral elbow creases, bottoms of bilateral feet.  Redness and swelling of mouth.  Patient was prescribed 80mg Depo-Medrol IM, 50 mg Benedryl IM, and sent out with 6 day Medrol Dose pack with OTC benedryl and pepcid.
Pt received vaccines on 6/2/09.  On 6/3/09 after pt got home from school, mom called office stating arms were now both red at injection sites and sore.  Advised at that time to apply cool compresses and take tylenol.  No fever, pt feeling okay, no respiratory problems.  On 6/4/09, spoke with pt's mom again and redness was spreading down his arms  - half-way to elbow on left, starting to spread down right as well. (left was worse than right arm).  Mom stating still no fever and no respiratory problems.  pt's arms red, swollen, and very sore.  Skin warm to the touch and skin feeling hard.  No blisters or open areas.  Pt unable to sleep due to this.  Per Dr. - pt with localized skin reactions on both arms.  Dr. prescribed CEFDINIR 300 MG PO CAPS 1 capsule daily for 10 days and listed diagnosis code as CELLULITIS OF ARM [682.3] as well.  Also on left arm, pt had diamond shaped bruise at injection site.  Otherwise, pt feeling fine.
10/09/2002 evening- temp 100-102.7, muscles aches , headache, 10/10/2002- temp increase 102.7. pt has had increase of temp for 7 days since 10/08/2002. Last pt seen by MD on day 6 given antibiotics and Allegra. Last night temp 103.7. Pt took 2 ASA BID- History triple bypass. 05/01 concerned with notting. MD examined pt. No apparent infection on OE
feels it's getting more itchy feel; there is the itchy feeling, then scratch and its feeling more on the face; rash that started on the forehead and expanded to the eyebrows, it went to nose, ears, cheeks; injection site there is a bump in the arm, very very little bump; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (feels it's getting more itchy feel), VACCINATION SITE PRURITUS (there is the itchy feeling, then scratch and its feeling more on the face), RASH (rash that started on the forehead and expanded to the eyebrows, it went to nose, ears, cheeks) and VACCINATION SITE SWELLING (injection site there is a bump in the arm, very very little bump) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRURITUS (feels it's getting more itchy feel), VACCINATION SITE PRURITUS (there is the itchy feeling, then scratch and its feeling more on the face), RASH (rash that started on the forehead and expanded to the eyebrows, it went to nose, ears, cheeks) and VACCINATION SITE SWELLING (injection site there is a bump in the arm, very very little bump). The patient was treated with LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) at an unspecified dose and frequency. At the time of the report, PRURITUS (feels it's getting more itchy feel), VACCINATION SITE PRURITUS (there is the itchy feeling, then scratch and its feeling more on the face), RASH (rash that started on the forehead and expanded to the eyebrows, it went to nose, ears, cheeks) and VACCINATION SITE SWELLING (injection site there is a bump in the arm, very very little bump) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were provided
Severe flu - for over a week. Fatigue, thyroid, immune compromised, food sensitivity battling hair loss on head, eyelashes and eye brows no more hair on legs, arm pits and arms
patient tested COVID + on 10/26/2021 despite being fully vaccinated.  He presented to the ED on the same day with cough and shortness of breath increasing for 3 days.  Denied chest pain.  Endorses mild myalgias.  Tachycardic with heart rate in the 130s.  Admitted to the ICU for supportive care for diabetic ketoacidosis, rhabdomylysis and hyperbilirubinemia. (not b/c of COVID it seems)
Redness and at the injection site, night sweating, chill, fever, headache, generally feeling sick. No medical treatment recommended since patient said she was feeling better at the time of reporting to the pharmacy
Systemic: Dizziness / Lightheadness-Mild, Systemic: Fainting / Unresponsive-Mild, Systemic: Nausea-Mild, Systemic: Vomiting-Mild, Additional Details: Approximately 2-3min after injection, patient briefly fainted then became concious and experienced nausea/vomiting. Called paramedic, but the vitals were normal and patient didn't use emergency service.  Called mother about 1-2 hours later at home, and patient eating, drinking and doing ok.
CVA - exam by ED/telestroke providers with L sided field cut concerning for R occipital stroke. He received TNK . Admitted to Facility post TNK. Today the patient reports that visual field deficits have resolved and he feels back at baseline. Discharged home and will follow up outpatient. ED visit to hospital admission within 6 weeks of receiving the COVID vaccine.
This case was reported by a pharmacist via call center representative and described the occurrence of generalized pruritus in a 70-year-old female patient who received SHINGRIX for prophylaxis. Concomitant products included SHINGRIX. On 25th April 2018, the patient received the 2nd dose of SHINGRIX (intramuscular) .5 ml. On an unknown date, several weeks after receiving SHINGRIX and an unknown time after receiving SHINGRIX, the patient experienced generalized pruritus. On an unknown date, the outcome of the generalized pruritus was not recovered/not resolved. It was unknown if the reporter considered the generalized pruritus to be related to SHINGRIX. Additional details were provided as follows: On 20th February 2018, the patient received 1st dose of the SHINGRIX vaccine on left arm. Few weeks after getting the 2nd dose, the patient experienced itching all over the body. The patient visited their allergy doctor. The patient went through allergy test, had molds checked in her house, changed detergent and perfumes. The patient at the time of reporting was experiencing itching. Emergency visit was required. No further details were provided.
Chills; fever; headache; This is a spontaneous report from a contactable other healthcare professional (patient). A 48-years-old non-pregnant female patient received bnt162b2 (BNT162B2, Lot number was not reported), dose 2 via an unspecified route of administration, administered in right arm on 12Mar2021 17:30 (at the age of 48-year-old) as dose 2, single for COVID-19 immunization in the Hospital. Medical history included hypothyroidism and allergy to shrimp. Concomitant medications included fexofenadine hydrochloride (ALLEGRA) and levothyroxine sodium (SYNTHROID).  The patient previously took naproxen and experienced allergies. The patient previously received the first dose of bnt162b2 administered in left arm on 20Feb2021 18:00 (at the age of 48-year-old) as single dose for COVID-19 immunization. No other vaccine in four weeks. No Covid prior vaccination nor tested with Covid post vaccination. On 13Mar2021 17:00, the patient experienced chills, fever and headache. The patient received no treatment for the events. The outcome of the events recovered on unspecified date in 2021.    No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
PATIENT HAD EPISODES OF ANGINAL CHEST PAIN BEGINNING AFTER 2ND COVID VACCINE, EVENTUALLY PRESENTED TO ER + DAYS AFTER VACCINATION. ECG WITH SR. < 1 MIN ST ELEVATION INFERIORLY.  ECHO W/ MILD INFEROBASIC HYPOKINESIS BUT NORMAL LVEF SSY.. LHC SHOWED NORMAL CORONARY ARTERIES.  TROPONIN  5.19 -> 13.5 -> 4.07 (ALL ABNORMAL) DX WITH MYOCARDITIS/PERICARDITIS. RECOVERED WELL WITHOUT COMPLICATIONS. TX INCLUDED NSAIDS, COLCHICINE.
LOOKED REALLY PALE; Stomach upset; SLEPT MOST OF THE DAY AWAY; RIGHT HAND SWOLLEN LIKE A BALLOON; RIGHT HAND COULD NOT CLOSE AND HURTING; RIGHT HAND COULD NOT CLOSE AND HURTING; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (RIGHT HAND SWOLLEN LIKE A BALLOON), ABDOMINAL DISCOMFORT (Stomach upset), JOINT RANGE OF MOTION DECREASED (RIGHT HAND COULD NOT CLOSE AND HURTING), SOMNOLENCE (SLEPT MOST OF THE DAY AWAY) and PALLOR (LOOKED REALLY PALE) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Osteoarthritis.    Concurrent medical conditions included Osteoarthritis (BONE ON BONE ARTHRITIS).   In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In February 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 24-Nov-2021, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) UNK, Citrate Free, Solution for injection in pre-filled pen. On 03-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In 2021, the patient experienced PERIPHERAL SWELLING (RIGHT HAND SWOLLEN LIKE A BALLOON), JOINT RANGE OF MOTION DECREASED (RIGHT HAND COULD NOT CLOSE AND HURTING) and PAIN IN EXTREMITY (RIGHT HAND COULD NOT CLOSE AND HURTING). On 04-Dec-2021, the patient experienced ABDOMINAL DISCOMFORT (Stomach upset) and SOMNOLENCE (SLEPT MOST OF THE DAY AWAY). On an unknown date, the patient experienced PALLOR (LOOKED REALLY PALE). In December 2021, ABDOMINAL DISCOMFORT (Stomach upset), SOMNOLENCE (SLEPT MOST OF THE DAY AWAY) and PALLOR (LOOKED REALLY PALE) had resolved. At the time of the report, PERIPHERAL SWELLING (RIGHT HAND SWOLLEN LIKE A BALLOON) had not resolved and JOINT RANGE OF MOTION DECREASED (RIGHT HAND COULD NOT CLOSE AND HURTING) and PAIN IN EXTREMITY (RIGHT HAND COULD NOT CLOSE AND HURTING) outcome was unknown.            Concomitant product use was not provided by the reporter.  In 2021, the patient experienced right hand swollen like a balloon/right hand could not close and hurting. On 04-Dec-2021, the patient experienced stomach upset, slept most of the day away and was looking pale. In Dec-2021, the stomach upset, slept most of the day away and was looking really pale resolved.  No treatment information was provided. The reporter's causality for the event hand swelling with Humira(adalimumab) was a reasonable possibility. The reporter's causality of Humira for the event(s) of abdominal discomfort, somnolence, and pallor was no reasonable possibility. The reporter's causality of Humira for the event joint range of motion decreased was not provided.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.      This case was linked to MOD-2021-623523 (Patient Link).   Reporter did not allow further contact
fever reaching 100.7F; chills; not able to lift her arm or head and could not get up until midnight (described as flu-like symptoms); This is a spontaneous report from a contactable other HCP. A female patient of 52-year-old received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), first dose via an unspecified route of administration on 30Jan2021, at unknown dose single for COVID-19 immunization. No medical history reported. No concomitant medications reported. On 30Jan2021 patient experienced at 9 in the evening was not able to lift her arm or head and could not get up until midnight (described as flu-like symptoms), fever reaching 100.7F which went down after 3-4 days, and chills. She wants to know how often these adverse effects happen on the first dose of the vaccine. The patient underwent Body temperature test. The outcome of Events for pyrexia was recovered and for other events was unknown.  Information on Lot /Batch Number has been requested.  Follow-up attempts are completed. No further information is expected.
Red rashes noted to back/neck and left sided of face. Patient was monitored for 45 minutes with no progression of rash or other discomfort. O2 Sat 98 on RA, HR 96. Patient was alert/talkative prior discharge left in stable condition with mother.
It was reported that an 18 year old male pt received a Menomune A/C/Y/W-135 vaccination and a PPD-Tubersol skin test on 6/27/00. Reportedly, on 6/28/00, the pt developed a temperature of 100F and dizziness. A physician did not evaluate the pt. Further information requested. From correspondence received on 8/8/00, it was reported that the pt recovered from this experience. No further information is expected, this case is closed.
January 2021 she had the first Covid vaccination but within an hour developed shortness of breath, chest discomfort was told she developed congestive heart failure with a markedly elevated BNP.  She was instructed not to receive the second Covid vaccination. In January 2022 she received the Pfizer vaccine. No documented allergy to it at this time.
After receiving the shot, my arm was sore. Sunday, March 14, around 6 am, I woke up with a slight fever.  My fever was around 100 all day.  I was also very fatigued. Monday, March 15, I woke up around 5 am and I had a rash over my chest, upper arms, front and back of neck, and on my back. I contacted my health provider and they gave me prednisone to take for 5 days.
Vials were refrigerated on 15-Jun-2022, but was administered to patient on 19-Jul-2022; Patient received vaccine after the 30 days beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received vaccine after the 30 days beyond use date) and PRODUCT STORAGE ERROR (Vials were refrigerated on 15-Jun-2022, but was administered to patient on 19-Jul-2022) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 060A22A) for COVID-19 vaccination.     Patient had no known drug allergies.  It was unknown whether the patient ever been diagnosed with/ tested positive for COVID-19.  It was unknown whether the patient had acute illnesses at the time of vaccination and up to one month before.  It was unknown whether the patient had chronic or long-standing health conditions.  t was unknown whether prescriptions, over-the-counter medications, dietary supplements, or herbal remedies being taken at time of vaccination and/or at the time of the adverse event.     On 19-Jul-2022 at 4:40 PM, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 19-Jul-2022 at 4:40 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received vaccine after the 30 days beyond use date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vials were refrigerated on 15-Jun-2022, but was administered to patient on 19-Jul-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received vaccine after the 30 days beyond use date) and PRODUCT STORAGE ERROR (Vials were refrigerated on 15-Jun-2022, but was administered to patient on 19-Jul-2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered EXPIRED PRODUCT ADMINISTERED (Patient received vaccine after the 30 days beyond use date) to be not related. No further causality assessment was provided for PRODUCT STORAGE ERROR (Vials were refrigerated on 15-Jun-2022, but was administered to patient on 19-Jul-2022).    Concomitant medications details were not reported by the reporter.  Patient reported no adverse events.   The events did not cause the patient to seek medical care.  There were no other potential causes.  Patient had not experienced a similar event in the past.  Treatment information was not reported by the reporter
No symptoms including pain, redness or swelling were seen or reported at the time of vaccine and patient was in clinic well over 15 minutes once vaccine was given. After vaccine patient was in clinic for a well woman exam with pap smear. Patient had a virtual visit with Dr. 11/13/2020 reporting right arm & hand swelling but the arm swelling had gone down and at that point was only the right hand. Patient was prescribed ibuprofen 600mg and urged to follow up if swelling persisted past 3-5 days. Patient was seen again on 11/19/2020 for right hand edema by Dr. - per note: Reports having swelling on top of right hand  with decreased strength. Denies any current redness at injection site, fever, nausea, vomiting. Pain is worse when making a fist, no pain or swelling of smaller joints of the right hand. Patient was given diclofenac topical for pain. Advised to use moist heat and ice and follow up in 3 weeks with possible occupational therapy referral. Patient then had a virtual visit with PCM on 12/7/2020 for right hand pain and was referred to occupational therapy and PMR for evaluation of nerve testing as well as  x-ray of right hand. Patient was prescribed Gabapentin 100mg for nerve pain with advice to taper up to 300mg if needed. Patient was advised to follow up if needed.
had shingles; pain; so uncomfortable; shot was expired; This case was reported by a consumer via interactive digital media and described the occurrence of shingles in a 80-year-old patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, less than 2 weeks after receiving Shingles vaccine, the patient experienced shingles, pain, discomfort and expired vaccine used. On an unknown date, the outcome of the shingles and expired vaccine used were unknown and the outcome of the pain and discomfort were not recovered/not resolved.   It was unknown if the reporter considered the shingles, pain and discomfort to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 27-Apr-2022 Reporter's comments: This case was received from a patient via digital media. The patient turned 80 and in two weeks had shingles. The Shingles shot was expired and the doctor said worst case he had seen. Now 10 months later, the patient still had pain but received the 2 newest shots. The patient was so uncomfortable. Additional Supportive Information: The patient received expired Shingles vaccine, which led to expired vaccine used.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022AMR071859:Same reporter (deleted case)
Patient's husband reported in the morning of August 10 that the patient has experienced a severe pain which started to develop from the left arm and radiated to the entire body over the night after receiving FLUZONE and PREVNAR 13 shots on August 9. The pain was severe enough to keep patient awake all night. I called and spoke with patient at 12:00 PM on August 10. Patient says she is still in severe body pain. She says her pain prevents her from leaving home to see her doctor. I instructed her to take either Motrin or Tylenol for the pain.
feel like her energy load was down; exhausted; immediate boom on her chest/heart like nothing she has experienced before; felt lousy after the 1st dose and hasn't bounced back from that; Med Info Agent: Return call to Safety crosslink case MOD21-072378. Updated email for contact
fever 8 days p/vax followed by gen rash & fever;29APR98 T101 tympanic rash 27APR98;otherwise states Ok;
Menstrual cycle abnormalities. Spotting/bleeding at abnormal times in cycle.